A Study of the Safety and Effectiveness of Galantamine in Patients With Alzheimer's Disease
Clinical trial NCT00216502 · COMPLETED
Trial details
- NCT number
- NCT00216502
- Sponsor
- Janssen-Cilag S.p.A.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2001-08-01
- Enrollment
- 254
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.